COVID-19: At-home sample collection vs. at-home testing - Insights
The concept of at-home testing for COVID-19 sounds straightforward. But there's nuance to it that's important to understand. Right now, an at-home test for COVID-19 is not available, although there may be one coming soon. But in some areas,...
Week in Review: June 3 - Insights
Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.
Week in Review: May 27 - Insights
Today's highlights include: Long COVID affects more older adults, US has a new dominant COVID-19 strain, and Gianrico Farrugia explains how we can transform healthcare by moving from pipeline to platform.
COVID-19 weekly news: March 7-11 2022 - Insights
Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.
COVID-19 weekly news: March 28-April 3 2022 - Insights
Topic's Include: Transplant, new model of care give hope to Salvadoran mom after cancer diagnosis, what you need to know about the COVID-19 BA.2 subvariant, and why calling the highly contagious COVID-19 omicron BA.2 a ‘stealth variant’ is...
Clinical Case Studies - Insights
The Pathways program provides anatomic and clinical pathology cases that include a history, potential answers, rationale, and relevant references directly from Mayo Clinic fellows, physicians, scientists, and allied health staff.
Nonalcoholic Steatohepatitis (NASH)-FibroTest* [Test in Focus] - Insights
Nikola Baumann, Ph.D., gives an overview of the new NASH-FibroTest available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...
Mayo Clinic's Accurate Amyloidosis Typing Test Leads to Effective Treatment - Insights
When the type of amyloidosis is appropriately determined by accurate and effective laboratory testing, it can be treated properly.
Autoimmune Peripheral Neuropathy: A New Paradigm Shift - Insights
PACE / State of FLThis webinar will discuss the advantages of using electrophysiology results to guide the selection of axonal or demyelinating testing for peripheral neuropathy. This approach can help identify specific antibodies...
What's New in Quality and Regulatory? [2024] - Insights
PACE/State of FL - Presentation Recording Coming Soon This webinar provides an overview of recent operational updates to the Clinical Laboratory Improvement Amendments (CLIA) and administrative process changes in the Centers for Medicare &...
Problem-Solving Thinking: An Overview of DMAIC, A3, and PDSA - Insights
PACE/State of FL - This presentation will give learners an understanding of what problem-solving thinking is, as well as an overview of what DMAIC, A3, and PDSA problem-solving approaches are to support your quality and continuous...
Pathways Case Studies: February 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Anatomic Pathology,...
Breath Diagnostics, Inc. and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The two...
Pathology consultation - Insights
Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.
September 2023 - Cytogenetics & Hematopathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cytogenetics & Hematopathology.
July 2023 - Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...
Connect with us at the 65th American Society of Hematology Annual Meeting and Exposition to learn how our evaluations can inform your clinical practice. Schedule a one-on-one session with our representatives.
Exocrine pancreatic insufficiency - Insights
Stool testing is a critical component of diagnosing exocrine pancreatic insufficiency (EPI), and Mayo Clinic Laboratories offers several tests to help clinicians evaluate these patients. A 48- or 72-hour stool fecal fat test is useful for...
Our interactive learning modules encompass many of the necessary skills to further develop your knowledge and skills on your journey as a phlebotomist.
Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides possadasi/immitis, Histoplasma, Blastomyces, and...
Introduction to Phlebotomy - Insights
Learn about collection tubes, inversions, and additives, and the recommended order of draw will be reviewed, along with general specimen labeling requirements and a summary of key phlebotomy terminology.
Fundamentals of Phlebotomy - Insights
Find out about the patient experience and patient privacy, and the inpatient and outpatient identification process, as well as the legal considerations that a phlebotomist needs to be aware of and a summary of key phlebotomy terminology.
Autoimmune neurology evolution - Insights
Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.
Check out Mayo Clinic Laboratories’ expert-developed screening and panel testing for lysosomal disorders (LDs).
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Learn about our sponsored testing program and how it can benefit both patients and healthcare providers.
Find out how our Candida auris polymerase chain reaction assay detects and identifies C. auris from surveillance swabs.
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Malabsorption disorders - Insights
Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...
Helicobacter pylori, or H. pylori, is one of the world’s most common chronic bacterial infections. Estimated to impact 4.4 billion individuals globally, H. pylori affects 35% to 89% of children, depending the on the geographic region in...
Autoimmune Liver Disease Testing - Mayo Clinic Laboratories
Our panel evaluates smooth muscle antibodies (SMA), antinuclear antibodies (ANA), and antimitochondrial antibodies (AMA) for patients with suspected autoimmune liver disease, specifically type 1 AIH or PBC or with liver disease of unknown...
Hepatocellular carcinoma - Insights
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer in the world. While HCC can be effectively treated in its early stages, most patients are not diagnosed until they are symptomatic and at higher grades and...
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
Bone and Soft Tissue Pathology Services at Mayo Cinic Laboratories
At Mayo Clinic, we excel in our approach to work collaboratively with radiology, surgery, and clinical practice to bring the highest quality.
Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy...
New tests launched in April - Insights
In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Communiqué Archives - Page 4 of 4 - Insights
Skip to Content MayoACCESS MayoLINK...
Autoimmune Gastrointestinal Dysmotility Evaluation [Test in Focus] - Insights
Divyanshu (Div), Dubey, M.B.B.S, gives an overview of the new Autoimmune Gastrointestinal Dysmotility Evaluation available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to...
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...
Urinary Steroid Profile [Test in Focus] - Insights
Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken...
Learn why liquid biopsy testing is a viable alternative to tissue-based biopsy testing for certain patients with cancer.
Disease-specific panels - Insights
Learn how disease-specific cancer panels help providers understand their patients’ risk of having a hereditary cancer syndrome.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
Histiocytic neoplasms - Insights
Learn more about how Mayo Clinic Laboratories’ next-generation sequencing panel for histiocytic neoplasms can help physicians accurately diagnose patients and guide treatment for their patients.
Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Chronic lymphocytic leukemia - Insights
Learn how we increase the quality of care by performing all of our chronic lymphocytic leukemia testing at a single facility.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.